tiprankstipranks
Hydrix Limited (AU:HYD)
ASX:HYD
Australian Market
Want to see AU:HYD full AI Analyst Report?

Hydrix Limited (HYD) AI Stock Analysis

2 Followers

Top Page

AU:HYD

Hydrix Limited

(Sydney:HYD)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
AU$0.01
▲(20.00% Upside)
Action:Upgraded
Date:05/20/26
The score is primarily held down by weak financial performance: ongoing losses, persistent negative operating/free cash flow, and negative shareholder equity. Technicals provide only mild support (small positive MACD and price above short-term averages), while valuation is constrained by negative earnings and no stated dividend yield.
Positive Factors
Specialized medtech engineering & regulatory services
Hydrix’s core business is high-value engineering and regulatory services for medical devices. These capabilities create durable client stickiness across long device development cycles, support recurring regulatory/maintenance revenue, and raise barriers to entry versus generalist engineering firms.
Negative Factors
Consistent operating losses and negative operating cash flow
Persistent operating losses and negative operating cash flow across years signal the business is not yet self-sustaining. Continued negative cash generation forces reliance on external capital, constrains reinvestment in growth, and raises the risk of dilution or restructurings.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized medtech engineering & regulatory services
Hydrix’s core business is high-value engineering and regulatory services for medical devices. These capabilities create durable client stickiness across long device development cycles, support recurring regulatory/maintenance revenue, and raise barriers to entry versus generalist engineering firms.
Read all positive factors

Hydrix Limited (HYD) vs. iShares MSCI Australia ETF (EWA)

Hydrix Limited Business Overview & Revenue Model

Company Description
Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally. It operates through two segments: Hydrix Services and Hydrix Medical. It provides cardiovascular prod...
How the Company Makes Money
Hydrix Limited generates revenue through a combination of engineering design consulting services and the sale of advanced medical devices. The company earns income by offering its design and development expertise to clients who require specialized...

Hydrix Limited Financial Statement Overview

Summary
Despite a notable improvement in 2025 (stronger gross margin and a much smaller net loss), the company remains loss-making with negative operating profitability, consistently negative operating/free cash flow, and a materially weakened balance sheet marked by negative shareholder equity—elevating financial risk.
Income Statement
28
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue9.33M10.09M10.61M13.16M10.33M7.45M
Gross Profit3.93M9.53M9.79M-638.73K-3.31M-6.46M
EBITDA-2.43M-1.40M-7.92M1.30M-4.05M-6.34M
Net Income-4.62M-2.92M-9.56M-396.93K-5.55M-9.78M
Balance Sheet
Total Assets6.61M8.35M8.62M14.58M15.94M19.38M
Cash, Cash Equivalents and Short-Term Investments584.18K297.88K914.27K1.15M1.94M6.65M
Total Debt10.33M7.98M7.61M4.73M5.40M5.97M
Total Liabilities15.72M14.39M11.98M8.22M12.66M13.67M
Stockholders Equity-9.10M-6.04M-3.36M6.35M3.28M5.71M
Cash Flow
Free Cash Flow-1.30M-535.13K-1.91M-3.32M-6.75M-3.35M
Operating Cash Flow-1.29M-527.01K-1.89M-3.12M-6.58M-2.86M
Investing Cash Flow-30.84K-54.20K-53.43K-209.71K-306.65K-641.56K
Financing Cash Flow980.73K-36.31K1.71M2.16M1.72M7.53M

Hydrix Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.01
Price Trends
50DMA
100DMA
200DMA
Market Momentum
MACD
<0.01
Positive
RSI
100.00
Negative
STOCH
82.44
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HYD, the sentiment is Positive. The current price of 0.01 is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 82.44 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:HYD.

Hydrix Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
50
Neutral
AU$5.01M0.9226.81%-17.34%
43
Neutral
AU$45.98M-2.36-102.57%-25.87%-150.00%
43
Neutral
AU$15.53M-2.00227.23%4.08%-6.25%
42
Neutral
AU$3.89M-0.75-53.27%5.00%-1714.29%
41
Neutral
AU$34.37M-0.3561.09%-9.40%21.19%
41
Neutral
AU$5.92M-0.53209.30%-13.81%-37.77%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:HYD
Hydrix Limited
0.02
<0.01
80.00%
AU:X2M
X2M Connect Limited
0.01
-0.01
-50.00%
AU:DVL
dorsaVi Limited
0.04
0.03
280.00%
AU:BCC
Beam Communications Holdings Limited
0.06
0.02
70.59%
AU:SIS
Simble Solutions Ltd.
AU:KNO
Knosys Ltd.
0.02
-0.02
-45.45%

Hydrix Limited Corporate Events

Hydrix posts strongest quarterly revenue in a year as services growth narrows cash loss
Apr 29, 2026
Hydrix Limited reported its strongest quarterly revenue in 12 months, with Hydrix Services generating $2.7 million in the March quarter, up 17% on the prior quarter and 15% on the previous corresponding period. The company also secured $3.9 millio...
Hydrix Swings to Deeper Half-Year Loss as Project Timing Hits Revenue
Feb 27, 2026
Hydrix Limited reported a 14% decline in half-year revenues to $4.84 million for the period ended 31 December 2025, reflecting delays in new client project starts and the completion of existing development programs. The company does not plan to pa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 20, 2026